Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-39758979 in Uncontrolled, Persistent Asthma
NCT01493882Phase 2Withdrawn
- Sponsor
- Johnson & Johnson
- Start
- Mar 2012
- Primary completion
- Jun 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of JNJ-39758979 in asthma, sponsored by Johnson & Johnson. Planned start Mar 2012; status: withdrawn.
02
Drugs
JNJ-39758979
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01493882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01493882.